Jefferies Group’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-241,400
Closed -$42.8M 2270
2020
Q1
$42.8M Sell
241,400
-470,000
-66% -$88.5M 0.47% 18
2019
Q4
$136M Sell
711,400
-26,400
-4% -$4.76M 1.05% 10
2019
Q3
$124M Buy
737,800
+470,800
+176% +$76.7M 0.96% 3
2019
Q2
$44.7M Buy
267,000
+251,300
+1,601% +$34.8M 0.33% 32
2019
Q1
$2.3M Sell
15,700
-35,300
-69% -$5.12M 0.02% 844
2018
Q4
$6.82M Buy
51,000
+36,200
+245% +$5.93M 0.06% 307
2018
Q3
$2.82M Sell
14,800
-28,900
-66% -$5.31M 0.02% 817
2018
Q2
$7.29M Sell
43,700
-2,300
-5% -$369K 0.04% 359
2018
Q1
$7.74M Sell
46,000
-87,800
-66% -$14.7M 0.04% 318
2017
Q4
$21.9M Buy
133,800
+35,400
+36% +$6.35M 0.1% 115
2017
Q3
$20.2M Buy
98,400
+21,800
+28% +$5.07M 0.13% 121
2017
Q2
$18.6M Sell
76,600
-35,600
-32% -$8.37M 0.12% 144
2017
Q1
$26.8M Sell
112,200
-1,061,200
-90% -$247M 0.2% 75
2016
Q4
$246M Sell
1,173,400
-1,047,500
-47% -$217M 1.38% 6
2016
Q3
$511M Buy
2,220,900
+39,200
+2% +$9.58M 2.64% 4
2016
Q2
$504M Buy
2,181,700
+135,900
+7% +$31.3M 2.29% 5
2016
Q1
$548M Buy
2,045,800
+298,800
+17% +$85.5M 3.16% 4
2015
Q4
$546M Buy
1,747,000
+1,611,700
+1,191% +$480M 3.1% 4
2015
Q3
$36.8M Buy
135,300
+115,200
+573% +$35.4M 0.21% 82
2015
Q2
$6.1M Sell
20,100
-1,258,200
-98% -$375M 0.03% 441
2015
Q1
$380M Buy
1,278,300
+1,182,300
+1,232% +$337M 2.12% 6
2014
Q4
$24.7M Buy
96,000
+65,500
+215% +$16.4M 0.15% 122
2014
Q3
$7.36M Sell
30,500
-64,800
-68% -$14.5M 0.05% 312
2014
Q2
$21.3M Buy
+95,300
New +$19.7M 0.18% 97
2013
Q3
Sell
-7,500
Closed -$947K 2295
2013
Q2
$947K Buy
+7,500
New +$849K 0.01% 804

Other funds holding AGN

Jefferies Group's AGN Position: Q2 2020 in Review

Jefferies Group sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 269,542 shares — an estimated $47.7M sold.

Jefferies Group first reported a position in AGN in Q2 2014 and held it in 24 quarters. The position peaked at $81.1M in Q2 2016. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Jefferies Group reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Jefferies Group sold 269,542 Allergan plc shares in Q2 2020, an estimated $47.7M.
  • Jefferies Group first reported a position in Allergan plc in Q2 2014 and held it in 24 quarters.
  • Jefferies Group's Allergan plc position peaked at $81.1M in Q2 2016.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Jefferies Group's 13F filing for Q2 2020, filed 14 Aug 2020.